Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
Sign Up to like & getrecommendations! Published in 2017 at "Blood Cancer Journal"
DOI: 10.1038/bcj.2017.76
Abstract: The recent remarkable advances in multiple myeloma (MM) therapy and outcomes have had mixed impact on patients with adverse risk genetics, many of whom continue to have inferior outcomes. This applies particularly to deletion of… read more here.
Keywords: del 17p; timing tp53; prevalence timing; tp53 mutations ... See more keywords